Connection

JAMES POOL to Humans

This is a "connection" page, showing publications JAMES POOL has written about Humans.
Connection Strength

0.187
  1. Clinical role of direct renin inhibition in hypertension. Am J Ther. 2012 May; 19(3):204-10.
    View in: PubMed
    Score: 0.011
  2. Effect of a physician uncertainty reduction intervention on blood pressure in uncontrolled hypertensives--a cluster randomized trial. J Gen Intern Med. 2012 Apr; 27(4):413-9.
    View in: PubMed
    Score: 0.011
  3. The role of baseline blood pressure in guiding treatment choice: a secondary analysis of the use of valsartan/hydrochlorothiazide as initial therapy in hypertensive adults in a randomized, double-blind, placebo-controlled trial. Clin Drug Investig. 2009; 29(12):791-802.
    View in: PubMed
    Score: 0.009
  4. Direct renin inhibition: focus on aliskiren. J Manag Care Pharm. 2007 Oct; 13(8 Suppl B):21-33.
    View in: PubMed
    Score: 0.008
  5. Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan. Am J Hypertens. 2007 Jan; 20(1):11-20.
    View in: PubMed
    Score: 0.008
  6. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults. Clin Ther. 2007 Jan; 29(1):61-73.
    View in: PubMed
    Score: 0.008
  7. Clinical pharmacology of antihypertensive therapy. Semin Nephrol. 2005 Jul; 25(4):215-26.
    View in: PubMed
    Score: 0.007
  8. Is it time to move to multidrug combinations? Am J Hypertens. 2003 Nov; 16(11 Pt 2):36S-40S.
    View in: PubMed
    Score: 0.006
  9. Once-daily treatment of patients with hypertension: a placebo-controlled study of amlodipine and benazepril vs amlodipine or benazepril alone. J Hum Hypertens. 2001 Jul; 15(7):495-8.
    View in: PubMed
    Score: 0.005
  10. Clinical significance of alpha1-adrenoceptor selectivity in the management of benign prostatic hyperplasia. Int Urol Nephrol. 2001; 33(3):407-12.
    View in: PubMed
    Score: 0.005
  11. The role of angiotensin II in hypertension and end-organ damage. Int J Clin Pract Suppl. 2000 Aug; (111):4-8.
    View in: PubMed
    Score: 0.005
  12. Prolonged fenoldopam infusions in patients with mild to moderate hypertension: pharmacodynamic and pharmacokinetic effects. Am J Hypertens. 1999 Sep; 12(9 Pt 1):906-14.
    View in: PubMed
    Score: 0.005
  13. Sustained hemodynamic effects of the selective dopamine-1 agonist, fenoldopam, during 48-hour infusions in hypertensive patients: a dose-tolerability study. J Clin Pharmacol. 1999 May; 39(5):471-9.
    View in: PubMed
    Score: 0.005
  14. Dose-response efficacy of valsartan, a new angiotensin II receptor blocker. J Hum Hypertens. 1999 Apr; 13(4):275-81.
    View in: PubMed
    Score: 0.004
  15. Dose-responsive antihypertensive efficacy of valsartan, a new angiotensin II-receptor blocker. Clin Ther. 1998 Nov-Dec; 20(6):1106-14.
    View in: PubMed
    Score: 0.004
  16. A randomized, double-blind, placebo-controlled, parallel-group, multicenter trial of four doses of tasosartan in patients with essential hypertension. Tasosartan Investigator's Group. Am J Hypertens. 1998 Apr; 11(4 Pt 1):454-61.
    View in: PubMed
    Score: 0.004
  17. Dose-related antihypertensive effects of irbesartan in patients with mild-to-moderate hypertension. Am J Hypertens. 1998 Apr; 11(4 Pt 1):462-70.
    View in: PubMed
    Score: 0.004
  18. Alpha adrenoceptor blockade in the treatment of benign prostatic hyperplasia: past, present and future. Br J Urol. 1997 Oct; 80(4):521-32.
    View in: PubMed
    Score: 0.004
  19. Use of the factorial design and quadratic response surface models to evaluate the fosinopril and hydrochlorothiazide combination therapy in hypertension. Am J Hypertens. 1997 Jan; 10(1):117-23.
    View in: PubMed
    Score: 0.004
  20. Doxazosin: a new approach to hypertension and benign prostatic hyperplasia. Br J Clin Pract. 1996 Apr-May; 50(3):154-63.
    View in: PubMed
    Score: 0.004
  21. Expanded Clinical Evaluation of Lovastatin (EXCEL) study results: two-year efficacy and safety follow-up. Am J Cardiol. 1994 Oct 01; 74(7):667-73.
    View in: PubMed
    Score: 0.003
  22. Role of the sympathetic nervous system in hypertension and benign prostatic hyperplasia. Br J Clin Pract Suppl. 1994 May; 74:13-7.
    View in: PubMed
    Score: 0.003
  23. Effects of doxazosin on coronary heart disease risk factors in the hypertensive patient. Br J Clin Pract Suppl. 1994 May; 74:8-12.
    View in: PubMed
    Score: 0.003
  24. Lovastatin and coadministered antihypertensive/cardiovascular agents. Hypertension. 1992 Mar; 19(3):242-8.
    View in: PubMed
    Score: 0.003
  25. Effect of angiotensin receptor blockade on insulin sensitivity and endothelial function in abdominally obese hypertensive patients with impaired fasting glucose. Clin Sci (Lond). 2012 Feb; 122(4):193-202.
    View in: PubMed
    Score: 0.003
  26. Combination antihypertensive therapy with terazosin and other antihypertensive agents: results of clinical trials. Am Heart J. 1991 Sep; 122(3 Pt 2):926-31.
    View in: PubMed
    Score: 0.003
  27. Peripheral and central blood pressure responses of combination aliskiren/hydrochlorothiazide and amlodipine monotherapy in African American patients with stage 2 hypertension: the ATLAAST trial. J Clin Hypertens (Greenwich). 2011 May; 13(5):366-75.
    View in: PubMed
    Score: 0.003
  28. Effects of doxazosin on serum lipids: a review of the clinical data and molecular basis for altered lipid metabolism. Am Heart J. 1991 Jan; 121(1 Pt 2):251-9; discussion 259-60.
    View in: PubMed
    Score: 0.003
  29. Antihypertensive effect of fosinopril, a new angiotensin converting enzyme inhibitor: findings of the Fosinopril Study Group II. Clin Ther. 1990 Nov-Dec; 12(6):520-33.
    View in: PubMed
    Score: 0.003
  30. Alpha 1-adrenoreceptor blockade and the molecular basis of lipid metabolism alterations. J Hum Hypertens. 1990 Oct; 4 Suppl 3:23-33.
    View in: PubMed
    Score: 0.002
  31. Review of the effects of doxazosin, a new selective alpha 1-adrenergic inhibitor, on lipoproteins in patients with essential hypertension. Am J Med. 1989 Aug 16; 87(2A):57S-61S.
    View in: PubMed
    Score: 0.002
  32. Does reducing physician uncertainty improve hypertension control?: rationale and methods. Circ Cardiovasc Qual Outcomes. 2009 May; 2(3):257-63.
    View in: PubMed
    Score: 0.002
  33. The impact of renal fusion and ectopia on aortic surgery. J Vasc Surg. 1988 Oct; 8(4):375-83.
    View in: PubMed
    Score: 0.002
  34. Clinical experience and rationale for angiotensin-converting enzyme inhibition with lisinopril as the initial treatment for hypertension in older patients. Am J Med. 1988 Sep 23; 85(3B):19-24.
    View in: PubMed
    Score: 0.002
  35. The Editor's Roundtable: Endothelial dysfunction in cardiovascular disease. Am J Cardiol. 2008 Aug 15; 102(4):418-23.
    View in: PubMed
    Score: 0.002
  36. A double-blind, randomized study evaluating losartan potassium monotherapy or in combination with hydrochlorothiazide versus placebo in obese patients with hypertension. Curr Med Res Opin. 2008 Apr; 24(4):1101-14.
    View in: PubMed
    Score: 0.002
  37. Terazosin (Hytrin): cumulative experience of clinical trials in the USA for the treatment of mild to moderate essential hypertension. Br J Clin Pract Suppl. 1987 Dec; 54:9-14.
    View in: PubMed
    Score: 0.002
  38. Plasma lipid lowering effects of doxazosin, a new selective alpha1 adrenergic inhibitor for systemic hypertension. Am J Cardiol. 1987 May 29; 59(14):46G-50G.
    View in: PubMed
    Score: 0.002
  39. Controlled multicenter study of the antihypertensive effects of lisinopril, hydrochlorothiazide, and lisinopril plus hydrochlorothiazide in the treatment of 394 patients with mild to moderate essential hypertension. J Cardiovasc Pharmacol. 1987; 9 Suppl 3:S36-42.
    View in: PubMed
    Score: 0.002
  40. Comparative effects of candesartan cilexetil and amlodipine in patients with mild systemic hypertension. Comparison of Candesartan and Amlodipine for Safety, Tolerability and Efficacy (CASTLE) Study Investigators. Am J Cardiol. 2001 Mar 15; 87(6):727-31.
    View in: PubMed
    Score: 0.001
  41. Plasma concentrations of propranolol and 4-hydroxypropranolol in man measured by high pressure liquid chromatography. Life Sci. 1979 Jan 15; 24(3):209-17.
    View in: PubMed
    Score: 0.001
  42. Valsartan, a new angiotensin II antagonist: antihypertensive effects over 24 hours. Clin Ther. 1997 May-Jun; 19(3):447-58; discussion 367-8.
    View in: PubMed
    Score: 0.001
  43. Muslin gauze in intracranial vascular surgery. Technical note. J Neurosurg. 1976 Jan; 44(1):127-8.
    View in: PubMed
    Score: 0.001
  44. Combined terazosin and verapamil therapy in essential hypertension. Hemodynamic and pharmacokinetic interactions. Am J Hypertens. 1995 Feb; 8(2):133-45.
    View in: PubMed
    Score: 0.001
  45. Antihypertensive and metabolic effects of concomitant administration of terazosin and methyclothiazide for the treatment of essential hypertension. J Clin Pharmacol. 1992 Apr; 32(4):351-9.
    View in: PubMed
    Score: 0.001
  46. Bifrontal craniotomy for anterior communicating artery aneurysms. J Neurosurg. 1972 Feb; 36(2):212-20.
    View in: PubMed
    Score: 0.001
  47. Expanded clinical evaluation of lovastatin (EXCEL) study results: IV. Additional perspectives on the tolerability of lovastatin. Am J Med. 1991 Jul 31; 91(1B):25S-30S.
    View in: PubMed
    Score: 0.001
  48. Expanded clinical evaluation of lovastatin (EXCEL) study results: III. Efficacy in modifying lipoproteins and implications for managing patients with moderate hypercholesterolemia. Am J Med. 1991 Jul 31; 91(1B):18S-24S.
    View in: PubMed
    Score: 0.001
  49. Nicardipine as antihypertensive monotherapy: positive effects on quality of life. J Hum Hypertens. 1991 Jun; 5(3):205-13.
    View in: PubMed
    Score: 0.001
  50. Expanded clinical evaluation of lovastatin (EXCEL) study: design and patient characteristics of a double-blind, placebo-controlled study in patients with moderate hypercholesterolemia. Am J Cardiol. 1990 Sep 18; 66(8):44B-55B.
    View in: PubMed
    Score: 0.001
  51. Spectrum of dysautonomia in mitral valvular prolapse. Am J Med. 1989 Mar; 86(3):267-74.
    View in: PubMed
    Score: 0.001
  52. Excision of cerebral arteriovenous malformations. J Neurosurg. 1968 Sep; 29(3):312-21.
    View in: PubMed
    Score: 0.001
  53. Gliomas in the region of the brain stem. J Neurosurg. 1968 Aug; 29(2):164-7.
    View in: PubMed
    Score: 0.001
  54. Effect of doxazosin monotherapy on blood pressure and plasma lipids in patients with essential hypertension. Am J Hypertens. 1988 Apr; 1(2):158-67.
    View in: PubMed
    Score: 0.001
  55. Isolated renal artery dissection secondary to medial degeneration. J Urol. 1988 Feb; 139(2):346-7.
    View in: PubMed
    Score: 0.001
  56. Neurosurgical management of carotid sinus hypersensitivity. Report of three cases. J Neurosurg. 1987 Nov; 67(5):757-9.
    View in: PubMed
    Score: 0.001
  57. Localization of ectopic pheochromocytomas by magnetic resonance imaging. Am J Med. 1987 Oct; 83(4):770-2.
    View in: PubMed
    Score: 0.001
  58. Mitral valve prolapse with symptoms of beta-adrenergic hypersensitivity. Beta 2-adrenergic receptor supercoupling with desensitization on isoproterenol exposure. Am J Med. 1987 Feb; 82(2):193-201.
    View in: PubMed
    Score: 0.000
  59. Antihypertensive activity of isradipine in humans: a new dihydropyridine calcium channel antagonist. Clin Pharmacol Ther. 1986 Dec; 40(6):694-7.
    View in: PubMed
    Score: 0.000
  60. Pharmacology of angiotensin converting enzyme inhibitors. A review. Am J Med. 1986 Oct 31; 81(4C):13-8.
    View in: PubMed
    Score: 0.000
  61. Suboccipital surgery for acoustic neurinomas: advantages and disadvantages. J Neurosurg. 1966 Feb; 24(2):483-92.
    View in: PubMed
    Score: 0.000
  62. Pharmacokinetics and pharmacodynamics of enalapril in patients with congestive heart failure and patients with hypertension. J Cardiovasc Pharmacol. 1985 Jul-Aug; 7(4):767-76.
    View in: PubMed
    Score: 0.000
  63. Propylbutyldopamine. Mechanism of blood pressure lowering in hypertensive patients. Hypertension. 1984 Mar-Apr; 6(2 Pt 2):I40-5.
    View in: PubMed
    Score: 0.000
  64. MENINGIOMAS OF THE FORAMEN MAGNUM. J Neurosurg. 1963 Sep; 20:740-51.
    View in: PubMed
    Score: 0.000
  65. Timing and techniques in the intracranial surgery of ruptured aneurysms of the anterior communicating artery. J Neurosurg. 1962 May; 19:378-88.
    View in: PubMed
    Score: 0.000
  66. Osteomas and mucoceles of the frontal paranasal sinuses. J Neurosurg. 1962 Feb; 19:130-5.
    View in: PubMed
    Score: 0.000
  67. Treatment of arteriovenous malformations of the cerebral hemispheres. J Neurosurg. 1962 Feb; 19:136-41.
    View in: PubMed
    Score: 0.000
  68. Total removal of recurrent acoustic tumors. J Neurosurg. 1961 Nov; 18:804-10.
    View in: PubMed
    Score: 0.000
  69. Aneurysms of the anterior communicating artery. Bifrontal craniotomy and routine use of temporary clips. J Neurosurg. 1961 Jan; 18:98-112.
    View in: PubMed
    Score: 0.000
  70. Plasma norepinephrine concentrations: no differences among normal volunteers and low, high or normal renin hypertensive patients. Life Sci. 1978 May 01; 22(17):1499-510.
    View in: PubMed
    Score: 0.000
  71. Mechanism and control of centrally induced cardiac irregularities during hypothermia. I. Clinical observations. J Neurosurg. 1958 Jan; 15(1):52-64.
    View in: PubMed
    Score: 0.000
  72. Renin-aldosterone profiling in hypertension. Ann Intern Med. 1977 Nov; 87(5):596-312.
    View in: PubMed
    Score: 0.000
  73. A double-blind placebo-controlled cross-over study with lidoflazine (Clinium) in post-infarction patients. Acta Med Scand. 1976; 199(1-2):17-23.
    View in: PubMed
    Score: 0.000
  74. Unilateral thoracic hyperhidrosis caused by osteoma of the tenth dorsal vertebra; case report. J Neurosurg. 1956 Jan; 13(1):111-5.
    View in: PubMed
    Score: 0.000
  75. The visceral brain of man. J Neurosurg. 1954 Jan; 11(1):45-63.
    View in: PubMed
    Score: 0.000
  76. The use of rheomacrodex in the surgery of intracranial aneurysms. J Neurosurg. 1967 Feb; 26(2):218-22.
    View in: PubMed
    Score: 0.000
  77. Pain in stimulating the distal segment of divided peripheral nerves. J Neurosurg. 1946 Nov; 3(6):468-73.
    View in: PubMed
    Score: 0.000
  78. Factors causing massive spasm following transection of the cord in man. J Neurosurg. 1946 Jul; 3:285-93.
    View in: PubMed
    Score: 0.000
  79. Ependymoma of spinal cord; subtotal intramedullary removal from syringomyelic cavity. J Neurosurg. 1946 Jul; 3:348-51.
    View in: PubMed
    Score: 0.000
  80. Electrospinogram (ESG); spinal cord action potentials recorded from a paraplegic patient. J Neurosurg. 1946 May; 3:192-8.
    View in: PubMed
    Score: 0.000
  81. Nerve stimulation in paraplegic patients by means of buried induction coil; preliminary report. J Neurosurg. 1946 May; 3:264-7.
    View in: PubMed
    Score: 0.000
  82. Electrical excitability of the human motor cortex. I. The parameters of the electrical stimulus. J Neurosurg. 1952 Sep; 9(5):461-71.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.